Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

Makragiannis, G; Vahdani, K; Carreño, E; Lee, RWJ; Dick, AD; Ross, AH; (2017) Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis. International Ophthalmology 10.1007/s10792-017-0502-x . (In press).

http://ift.tt/2pykXas